Product Development Reviewers


Leila Alland, MD
Chief Medical Officer
Tarveda Therapeutics

Michelle Arkin, PhD
Associate Adjunct Professor of Pharmaceutical Chemistry
University of California, San Francisco

C. Glenn Begley, PhD
Chief Scientific Officer and Senior Vice-President Research & Development
TetraLogic Pharmaceutical Corporation

Paul Benny, PhD
Associate Professor (Tenured)
Department of Chemistry
Washington State University

Renzo Canetta, MD
Independent Consultant

Nora Carbine
Advocacy Member
Georgetown Lombardi Breast Cancer Patient Advocacy Program

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Neil Clendeninn, MD, PhD
Senior Vice President & CMO
Heron Therapeutics
Drug Development Consultant primarily to the Pharmaceutical Industry

Roy Cosan
President
Renova Therapeutics

Ray DuBois, MD, PhD
Dean
Medical University of South Carolina

Robert Figlin, MD
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai

James Foley, PhD
Managing Director
Aqua Partners, LLC

Judy Fox, PhD
R&D Consultant
FoxBiopharma, LLC

Phyllis Gardner, MD
Professor of Medicine
Stanford University

Jack Geltosky, PhD
Managing Director
JEG and Associates, LLC

Stanton Gerson, MD
Director
Case Comprehensive Cancer Center and Seidman Cancer Center
Case Western Reserve University

Mara Ginsberg, JD
Founder & President
To Life!

Lee Greenberger, PhD
Chief Scientific Officer
Leukemia and Lymphoma Society

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Rao P. Gullapalli, PhD, MBA
Professor, Diagnostic Radiology and Nuclear Medicine
University of Maryland, Baltimore

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Herbert Hurwitz, MD
Professor of Medicine
Division of Medical Oncology
Duke University Medical Center

Elaine Jones, PhD
Executive Director
Venture Capital
Pfizer Inc.

Jim Jordan, MBA
President
StraTactic, Inc

Gerard Kennealey, MD
Principal
Welshire Consulting

Robert Kramer, PhD
Self-employed
R A Kramer Consulting, LLC

Vivian Lee
Founder and Managing Director
Aqua Partners LLC

Yueming Li, PhD
Professor, Molecular Pharmacology and Chemistry Program
Memorial Sloan-Kettering Cancer Center

Ramona Lloyd, PhD, RAC
President
Cymreg Consulting

H. Kim Lyerly, MD
George Barth Geller Professor of Cancer Research and Professor of Surgery
Duke University Medical Center

Richard (Mac) McCloskey, MD
Scientific Adviser
Consultant
Johnson and Johnson

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Marcia Moore, MPH
Vice President, Development
Arvinas, Inc

Claude Nicaise, MD
Senior Vice President, Strategic Product Development & Global Regulatory Affairs
Alexion Pharmaceuticals

Mark Pegram, MD
Professor of Medicine
Stanford University

Terence Porter, PhD
Vice President, Search and Evaluation
Takeda Pharmaceuticals International

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

David Shoemaker, PhD
Senior Vice President, R&D
Rho, Inc

Sandra Silberman, MD, PhD
Independent Consultant to the Pharmaceutical / Biotech Industry
SLS Oncology, LLC

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Mike Vasconcelles, MD
SVP, Head of Oncology Clinical Development
Clinical Instructor in Medicine (Harvard)
Millennium: The Takeda Oncology Company
Harvard Medical School

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

David Weng, MD, PhD
Medical Oncologist
AAMC Oncology and Hematology

Grant Williams, MD
President
Williams Cancer Drug Consulting, LLC

Elizabeth Yamashita
VP, CMC Regulatory
Savient Pharmaceuticals, Inc

Nancy Zeleniak
President
N2Communications LLC

Product Development Panel-1 (PDP-1)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Michelle Arkin, PhD
Associate Adjunct Professor of Pharmaceutical Chemistry
University of California, San Francisco

Neil Clendeninn, MD, PhD
Senior Vice President & CMO
Heron Therapeutics
Drug Development Consultant primarily to the Pharmaceutical Industry

Roy Cosan
President
Renova Therapeutics

James Foley, PhD
Managing Director
Aqua Partners, LLC

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Elaine Jones, PhD
Executive Director
Venture Capital
Pfizer Inc.

Jim Jordan, MBA
President
StraTactic, Inc

Gerard Kennealey, MD
Principal
Welshire Consulting

Yueming Li, PhD
Professor, Molecular Pharmacology and Chemistry Program
Memorial Sloan-Kettering Cancer Center

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Product Development Panel-2 (PDP-2)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Ray DuBois, MD, PhD
Dean
Medical University of South Carolina

Phyllis Gardner, MD
Professor of Medicine
Stanford University

Mara Ginsberg, JD
Founder & President
To Life!

Richard (Mac) McCloskey, MD
Scientific Adviser
Consultant
Johnson and Johnson

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Nancy Zeleniak
President
N2Communications LLC

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Judy Fox, PhD
R&D Consultant
FoxBiopharma, LLC

Phyllis Gardner, MD
Professor of Medicine
Stanford University

Mara Ginsberg, JD
Founder & President
To Life!

Elaine Jones, PhD
Executive Director
Venture Capital
Pfizer Inc.

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Michelle Arkin, PhD
Associate Adjunct Professor of Pharmaceutical Chemistry
University of California, San Francisco

Neil Clendeninn, MD, PhD
Senior Vice President & CMO
Heron Therapeutics
Drug Development Consultant primarily to the Pharmaceutical Industry

Roy Cosan
President
Renova Therapeutics

Stanton Gerson, MD
Director
Case Comprehensive Cancer Center and Seidman Cancer Center
Case Western Reserve University

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Jim Jordan, MBA
President
StraTactic, Inc

Ramona Lloyd, PhD, RAC
President
Cymreg Consulting

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Elizabeth Yamashita
VP, CMC Regulatory
Savient Pharmaceuticals, Inc

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Ray DuBois, MD, PhD
Dean
Medical University of South Carolina

Stanton Gerson, MD
Director
Case Comprehensive Cancer Center and Seidman Cancer Center
Case Western Reserve University

Mara Ginsberg, JD
Founder & President
To Life!

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Elaine Jones, PhD
Executive Director
Venture Capital
Pfizer Inc.

Gerard Kennealey, MD
Principal
Welshire Consulting

Yueming Li, PhD
Professor, Molecular Pharmacology and Chemistry Program
Memorial Sloan-Kettering Cancer Center

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

David Weng, MD, PhD
Medical Oncologist
AAMC Oncology and Hematology

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Nora Carbine
Advocacy Member
Georgetown Lombardi Breast Cancer Patient Advocacy Program

Neil Clendeninn, MD, PhD
Senior Vice President & CMO
Heron Therapeutics
Drug Development Consultant primarily to the Pharmaceutical Industry

Robert Figlin, MD
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai

Judy Fox, PhD
R&D Consultant
FoxBiopharma, LLC

Lee Greenberger, PhD
Chief Scientific Officer
Leukemia and Lymphoma Society

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Jim Jordan, MBA
President
StraTactic, Inc

H. Kim Lyerly, MD
George Barth Geller Professor of Cancer Research and Professor of Surgery
Duke University Medical Center

Richard (Mac) McCloskey, MD
Scientific Adviser
Consultant
Johnson and Johnson

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Claude Nicaise, MD
Senior Vice President, Strategic Product Development & Global Regulatory Affairs
Alexion Pharmaceuticals

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

Grant Williams, MD
President
Williams Cancer Drug Consulting, LLC

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Robert Figlin, MD
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Gerard Kennealey, MD
Principal
Welshire Consulting

Richard (Mac) McCloskey, MD
Scientific Adviser
Consultant
Johnson and Johnson

Claude Nicaise, MD
Senior Vice President, Strategic Product Development & Global Regulatory Affairs
Alexion Pharmaceuticals

Mark Pegram, MD
Professor of Medicine
Stanford University

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

Grant Williams, MD
President
Williams Cancer Drug Consulting, LLC

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Michelle Arkin, PhD
Associate Adjunct Professor of Pharmaceutical Chemistry
University of California, San Francisco

Nora Carbine
Advocacy Member
Georgetown Lombardi Breast Cancer Patient Advocacy Program

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Roy Cosan
President
Renova Therapeutics

Ray DuBois, MD, PhD
Dean
Medical University of South Carolina

Mara Ginsberg, JD
Founder & President
To Life!

Herbert Hurwitz, MD
Professor of Medicine
Division of Medical Oncology
Duke University Medical Center

Robert Kramer, PhD
Self-employed
R A Kramer Consulting, LLC

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Nancy Zeleniak
President
N2Communications LLC

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Phyllis Gardner, MD
Professor of Medicine
Stanford University

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Jim Jordan, MBA
President
StraTactic, Inc

Vivian Lee
Founder and Managing Director
Aqua Partners LLC

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Marcia Moore, MPH
Vice President, Development
Arvinas, Inc

Mark Pegram, MD
Professor of Medicine
Stanford University

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

David Weng, MD, PhD
Medical Oncologist
AAMC Oncology and Hematology

Elizabeth Yamashita
VP, CMC Regulatory
Savient Pharmaceuticals, Inc

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Roy Cosan
President
Renova Therapeutics

Stanton Gerson, MD
Director
Case Comprehensive Cancer Center and Seidman Cancer Center
Case Western Reserve University

Lee Greenberger, PhD
Chief Scientific Officer
Leukemia and Lymphoma Society

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Vivian Lee
Founder and Managing Director
Aqua Partners LLC

Richard (Mac) McCloskey, MD
Scientific Adviser
Consultant
Johnson and Johnson

Mark Pegram, MD
Professor of Medicine
Stanford University

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Paul Benny, PhD
Associate Professor (Tenured)
Department of Chemistry
Washington State University

Judy Fox, PhD
R&D Consultant
FoxBiopharma, LLC

Mara Ginsberg, JD
Founder & President
To Life!

Rao P. Gullapalli, PhD, MBA
Professor, Diagnostic Radiology and Nuclear Medicine
University of Maryland, Baltimore

Elaine Jones, PhD
Executive Director
Venture Capital
Pfizer Inc.

Gerard Kennealey, MD
Principal
Welshire Consulting

Yueming Li, PhD
Professor, Molecular Pharmacology and Chemistry Program
Memorial Sloan-Kettering Cancer Center

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

David Weng, MD, PhD
Medical Oncologist
AAMC Oncology and Hematology

Grant Williams, MD
President
Williams Cancer Drug Consulting, LLC

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

C. Glenn Begley, PhD
Chief Scientific Officer and Senior Vice-President Research & Development
TetraLogic Pharmaceutical Corporation

James Foley, PhD
Managing Director
Aqua Partners, LLC

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Gwen Harding-Peets, PhD
Regional Coordinator
SHARE: Self-Help for Women with Breast or Ovarian Cancer

Robert Kramer, PhD
Self-employed
R A Kramer Consulting, LLC

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Marcia Moore, MPH
Vice President, Development
Arvinas, Inc

Terence Porter, PhD
Vice President, Search and Evaluation
Takeda Pharmaceuticals International

Sandra Silberman, MD, PhD
Independent Consultant to the Pharmaceutical / Biotech Industry
SLS Oncology, LLC

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Gabriel Cipau, PhD, MBA, MS
President
Key Healthcare Partners Inc

Neil Clendeninn, MD, PhD
Senior Vice President & CMO
Heron Therapeutics
Drug Development Consultant primarily to the Pharmaceutical Industry

Ray DuBois, MD, PhD
Dean
Medical University of South Carolina

Phyllis Gardner, MD
Professor of Medicine
Stanford University

Mara Ginsberg, JD
Founder & President
To Life!

Jim Jordan, MBA
President
StraTactic, Inc

Claude Nicaise, MD
Senior Vice President, Strategic Product Development & Global Regulatory Affairs
Alexion Pharmaceuticals

Bo Saxberg, MD, PhD
President
DDO Strategic Services, Inc

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

Product Development Panel-1 (PDP-1)

Jack Geltosky, PhD, Chair
Managing Director
JEG and Associates, LLC

Leila Alland, MD
Chief Medical Officer
Tarveda Therapeutics

Renzo Canetta, MD
Independent Consultant

Valerie Guild, MBA
President
AIM at Melanoma Foundation

Vivian Lee
Founder and Managing Director
Aqua Partners LLC

Marcia Moore, MPH
Vice President, Development
Arvinas, Inc

Robert Sarisky, PhD, MBA
Chief Business Officer
Forma Therapeutics

Ginette Serrero, PhD
Chief Executive Officer
A&G Pharmaceutical Inc.

Neil Spector, MD
Co-Director: Developmental Therapeutics Program
Duke Cancer Institute

Product Development Panel-2 (PDP-2)

David Shoemaker, PhD, Chair
Senior Vice President, R&D
Rho, Inc

Roy Cosan
President
Renova Therapeutics

Robert Figlin, MD
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai

Mara Ginsberg, JD
Founder & President
To Life!

Lee Greenberger, PhD
Chief Scientific Officer
Leukemia and Lymphoma Society

Mark Moasser, MD
Professor, Department of Medicine, Division of Hematology/Oncology
University of California, San Francisco

Sandra Silberman, MD, PhD
Independent Consultant to the Pharmaceutical / Biotech Industry
SLS Oncology, LLC

Colin Turnbull, PhD
President
Colin Turnbull Consulting LLC

Meryl Weinreb
President (Somerset)
Chair of Education and Public Policy (Komen)
Somerset Lake Consulting
Susan G Komen (Philadelphia affiliate)

* Proposed for membership. Appointment will be confirmed at the agency's next scheduled Oversight Committee meeting.